Curated from public registries including ClinicalTrials.gov and VeterinaryClinicalTrials.org; updated monthly. Suggest a study or sign up for trial alerts below.
🇺🇸 USA (San Francisco) · Cats · Overweight / obesity (GLP-1 weight loss)
Randomized, placebo-controlled trial of OKV-119, an ultra-long-acting exenatide implant delivering a GLP-1 agonist for up to 6 months from a single in-office implant, in ~50 client-owned overweight/obese cats. First cat dosed December 2025. FDA filing targeted 2027–2028. First-ever GLP-1 weight-loss trial in cats or dogs.
Investigated as targeted anti-infectives amid the antimicrobial-resistance crisis in companion animals and livestock.
Multi-institution · Companion & livestock research consortiaPeptideJournal · Wiley AMR review
Standard-of-careCompletedStandard-of-care
DDAVP for von Willebrand's disease — canine surgical hemostasis
🌐 Multi-country · Dogs · vWD bleeding control
Transiently raises vWF and shortens bleeding time in von Willebrand's disease, enabling surgery/bleeding control. Feline hemostatic effect not yet established.
Established clinical use · Veterinary teaching hospitalsBachem — Peptides in Veterinary Medicine
Standard-of-careCompletedValidated diagnostic
NT-proBNP — validated cardiac biomarker in dogs & cats
🇧🇷 Brazil · Dogs & Cats · Diagnose/monitor CHF
Validated cardiac biomarker for diagnosing and monitoring congestive heart failure in dogs and cats; fast in-clinic assays available.
Shanghai Jiao Tong University · SJTUPMC3671520 · PMC4963596
InvestigationalPreclinicalPreclinical
BPC-157 — ligament/GI repair (rodent models)
🌐 Multi-country · Rodent (preclinical) · Connective tissue & GI
Virtually all published evidence is from rodent models. Not approved for veterinary use. Used in some integrative canine practices under veterinary discretion.
Multi-academic · Multiple research groupsPeptideJournal · CIVT webinar
Stay current
Get monthly trial alerts.
One short email per month — what's new, what's recruiting, what changed status. No marketing.